Perspective Therapeutics, Inc. (CATX) stock
CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)
Close on Nov 20, 2026Market cap $86.05MP/E –Yield –
Perspective Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Perspective Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$93.07M. For fiscal 2025 it was -$82.48M. The highest annual figure on record is -$2.42M in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$82.48M | – |
| FY2024 | Dec 31, 2024 | -$18.29M | – |
| FY2022 | Jun 30, 2022 | -$7.71M | – |
| FY2021 | Jun 30, 2021 | -$2.84M | – |
| FY2020 | Jun 30, 2020 | -$3.64M | – |
| FY2019 | Jun 30, 2019 | -$5.05M | – |
| FY2018 | Jun 30, 2018 | -$5.71M | – |
| FY2017 | Jun 30, 2017 | -$5.71M | – |
| FY2016 | Jun 30, 2016 | -$3.88M | – |
| FY2015 | Jun 30, 2015 | -$3.52M | – |
| FY2014 | Jun 30, 2014 | -$3.23M | – |
| FY2013 | Jun 30, 2013 | -$3.06M | – |
| FY2012 | Jun 30, 2012 | -$2.45M | – |
| FY2011 | Jun 30, 2011 | -$2.42M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$20.65M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$31.47M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$24.66M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$16.29M | -584.0% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$19.95M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$21.58M | -255.8% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$26.61M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $3.37M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$8.90M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $13.85M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$2.89M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$1.42M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$1.31M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$2.08M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$1.12M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$621.00K | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$760.00K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$338.00K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$848.00K | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$862.00K | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$1.28M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$653.00K | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$985.00K | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$1.34M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$1.11M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$1.61M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$1.45M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$1.08M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$1.52M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$1.66M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$1.21M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$1.49M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$1.66M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$1.35M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$1.21M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$756.00K | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$811.00K | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$1.11M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$629.54K | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | -$1.13M | – |
See a number that looks wrong?